Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT04092556
Eligibility Criteria:
Inclusion Criteria:
* 1\. Patients who meet the clinical criteria for probable multiple system atrophy with cerebellar features (MDS second consensus statement on the diagnosis of multiple system atrophy)
* 2\. Patients aged between 40 and 70
* 3\. Patients who do not have rigidity and bradykinesia
* 4\. Patients who have given voluntary consent after understanding the content of the clinical trial
Exclusion Criteria:
* 1\. Patients with a serious cognitive disorder, behavioral disorder, or mental illness
* 2\. Patients have history of seizure, stroke, encephalitis, other degenerative neurological disease
* 3\. Patients with a serious medical disease
* Patients who concomitantly suffer from severe renal impairment, convulsions, stomach ulcers, moderate or more severe liver disease
* Patients with un-controlled high blood pressure or diabetes
* 4\. Patients who have taken another investigational products within 4 weeks prior to being enrolled in this clinical trial, or patients who are pregnant or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
70 Years
Study:
NCT04092556
Study Brief:
Protocol Section:
NCT04092556